Literature DB >> 18613082

Substantial overproduction of antibodies by applying osmotic pressure and sodium butyrate.

S K Oh1, P Vig, F Chua, W K Teo, M G Yap.   

Abstract

Much of the current cell technology has enabled increased antibody production levels due to judicious nutrient feeding to raise cell densities and design better bioreactors. This study demonstrates that hybridomas can be hyperstimulated to produce higher immunoglobulin (lg) levels by suppressing cell growth and increasing culture longevity through adaptation to higher osmolarity media and addition of sodium butyrate. Prior to adaptation, cells placed in higher osmotic pressures (350 and 400 mOsm) were severely suppressed in growth down to 25% of the control (300 mOsm), although total lg titers achieved were similar to the control, approximately 140 mg/L. After a week of adaptation to 350 and 400 mOsm media, cell growth was not as dramatically suppressed, but considerably higher lg levels were attained at these elevated osmolarities. The highest yield of 265 mg/L was obtained at 350 mOsm compared to 140 mg/L at 300 mOsm, while maximum viable cell numbers dropped from 35 x 10(5) cells/mL to 31 x 10(5) cells/mL and culture longevity was extended by 20 h more than the control. Sodium butyrate, known to enhance protein production in other cell types, was then supplemented at a range of concentrations between 0.01 and 0.4 mM to the 350 mOsm culture to further enhance the lg levels. Butyrate at a concentration of 0.1 mM, in combination with osmotic pressure at 350 mOsm, further elevated the lg levels to 350 mg/L. Concomitantly, maximum viable cell numbers were reduced to 22 x 10(5) cells/mL, but culture longevity was extended by 40 h in the 0.1 mM butyrate supplemented culture compared to the control condition. Specific antibody productivity, q(Mab), continued to stay high during the stationary phase and was further elevated during the decline phase: thus, overall lg levels can be increased by 2.3 times by combining osmotic pressure and butyrate treatment. (c) 1993 John Wiley & Sons, Inc.

Entities:  

Year:  1993        PMID: 18613082     DOI: 10.1002/bit.260420508

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  21 in total

1.  Biosynthesis of protein products by animal cells. Are growth and non-growth associated concepts valid or useful?

Authors:  J P Barford; P J Phillips; C P Marquis; C Harbour
Journal:  Cytotechnology       Date:  1996-06       Impact factor: 2.058

2.  Hybridoma cell behaviour in continuous culture under hyperosmotic stress.

Authors:  M Cherlet; A Marc
Journal:  Cytotechnology       Date:  1999-01       Impact factor: 2.058

3.  Effect of hypoosmotic pressure on cell growth and antibody production in recombinant Chinese hamster ovary cell culture.

Authors:  M S Lee; G M Lee
Journal:  Cytotechnology       Date:  2001-07       Impact factor: 2.058

4.  Enhanced monoclonal antibody production by gradual increase of osmotic pressure.

Authors:  J Lin; M Takagi; Y Qu; P Gao; T Yoshida
Journal:  Cytotechnology       Date:  1999-01       Impact factor: 2.058

5.  Variable functions of bcl-2 in mediating bioreactor stress- induced apoptosis in hybridoma cells.

Authors:  A Perani; R P Singh; R Chauhan; M Al-Rubeai
Journal:  Cytotechnology       Date:  1998-11       Impact factor: 2.058

6.  Reactor design for large scale suspension animal cell culture.

Authors:  J Varley; J Birch
Journal:  Cytotechnology       Date:  1999-05       Impact factor: 2.058

7.  Process development for functional membrane receptor production in mammalian cells.

Authors:  Christel Fenge; Irma Jansson; Thomas Fröberg; Marie Jönsson; Elke Lüllau; Linda Sygowski; Craig Moore; Dean Snyder; Michael Wood
Journal:  Cytotechnology       Date:  2002-01       Impact factor: 2.058

8.  The effect of alternative carbohydrates on the growth and antibody production of a murine hybridoma.

Authors:  D Petch; M Butler
Journal:  Appl Biochem Biotechnol       Date:  1996-04       Impact factor: 2.926

9.  Development of optimal medium for production of commercially important monoclonal antibody 520C9 by hybridoma cell.

Authors:  Sucharita Sen; Pradip K Roychoudhury
Journal:  Cytotechnology       Date:  2012-07-19       Impact factor: 2.058

10.  Optimal production and in vitro activity of recombinant endostatin from stably transformed Drosophila melanogaster S2 cells.

Authors:  J H Park; K H Chang; J M Lee; Y H Lee; I S Chung
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-01       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.